# Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

> **NCT00749021** · PHASE1 · COMPLETED · sponsor: **Clement K. Chan** · enrollment: 40 (actual)

## Conditions studied

- Retinal Pigment Epithelial Detachment

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab
- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT00749021
- **Lead sponsor:** Clement K. Chan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749021, "Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00749021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*